The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R,4S)-4-[Hydroxy-((R)-2-hydroxy-3-octadecanoyloxy-propoxy)-phosphoryloxy]-pyrrolidine-2-carboxylic acid ID: ALA584910
PubChem CID: 44475361
Max Phase: Preclinical
Molecular Formula: C26H50NO9P
Molecular Weight: 551.66
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O[C@@H]1CN[C@@H](C(=O)O)C1
Standard InChI: InChI=1S/C26H50NO9P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-25(29)34-20-22(28)21-35-37(32,33)36-23-18-24(26(30)31)27-19-23/h22-24,27-28H,2-21H2,1H3,(H,30,31)(H,32,33)/t22-,23+,24-/m1/s1
Standard InChI Key: IQWNCAYPTZMTSA-TZRRMPRUSA-N
Molfile:
RDKit 2D
37 37 0 0 0 0 0 0 0 0999 V2000
-3.1838 -14.9141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4678 -15.3275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7519 -14.9141 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-1.0359 -15.3275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3445 -14.1919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1712 -14.1919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3200 -14.9141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3960 -15.3275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1119 -14.9141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3960 -16.1542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8279 -15.3275 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5439 -14.9141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5439 -14.0874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2567 -15.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9707 -14.9058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6847 -15.3150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3987 -14.9016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1126 -15.3109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8266 -14.8975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5406 -15.3067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2546 -14.8933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9685 -15.3024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6825 -14.8891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3965 -15.2983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1105 -14.8850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8245 -15.2941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5384 -14.8808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2524 -15.2899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9664 -14.8766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6804 -15.2858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2750 -14.0901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0836 -13.9182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4970 -14.6343 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9438 -15.2485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4199 -13.1630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9340 -12.4941 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2421 -13.0765 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18 19 1 0
8 10 1 1
19 20 1 0
2 3 1 0
20 21 1 0
9 11 1 0
21 22 1 0
3 6 2 0
22 23 1 0
11 12 1 0
23 24 1 0
1 2 1 6
24 25 1 0
12 13 2 0
25 26 1 0
4 7 1 0
26 27 1 0
12 14 1 0
27 28 1 0
3 4 1 0
28 29 1 0
14 15 1 0
29 30 1 0
1 31 1 0
7 8 1 0
15 16 1 0
16 17 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 1 1 0
8 9 1 0
32 35 1 1
17 18 1 0
35 36 2 0
3 5 1 0
35 37 1 0
M END Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 551.66Molecular Weight (Monoisotopic): 551.3223AlogP: 5.10#Rotatable Bonds: 24Polar Surface Area: 151.62Molecular Species: ZWITTERIONHBA: 8HBD: 4#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.20CX Basic pKa: 10.93CX LogP: 3.41CX LogD: 0.65Aromatic Rings: ┄Heavy Atoms: 37QED Weighted: 0.07Np Likeness Score: 0.84
References 1. Iwashita M, Makide K, Nonomura T, Misumi Y, Otani Y, Ishida M, Taguchi R, Tsujimoto M, Aoki J, Arai H, Ohwada T.. (2009) Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of lysophosphatidylthreonine and its 2-deoxy derivative., 52 (19): [PMID:19743861 ] [10.1021/jm900598m ]